Fisher & Paykel Healthcare | FPH - Sales Revenues

Stock Price
27.40
Daily Change
0.73 2.74%
Monthly
-11.76%
Yearly
-16.54%
Q2 Forecast
26.49

Fisher & Paykel Healthcare reported NZD1.09B in Sales Revenues for its fiscal semester ending in September of 2025.





Sales Change Date
Cochlear AUD 1.18B 590.35M Dec/2025
CSL USD 8.33B 4.79B Dec/2025
Nanosonics AUD 102.23M 2.8M Dec/2025
Ramsay Health Care AUD 9.34B 82.2M Dec/2025
ResMed USD 1.42B 87.23M Dec/2025
Somnomed AUD 45.11M 1.46M Dec/2023
Sonic Healthcare AUD 5.45B 470M Dec/2025